Top 10 Generic Over-the-Counter (OTC) Medicine Manufacturers in Poland

Robert Gultig

5 January 2026

Top 10 Generic Over-the-Counter (OTC) Medicine Manufacturers in Poland

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The pharmaceutical industry in Poland has been experiencing significant growth in recent years, with an increasing demand for generic over-the-counter (OTC) medicines. The market size for OTC medicines in Poland is estimated to be around $1.5 billion, with a production volume of over 500 million units annually. This report will highlight the top 10 generic OTC medicine manufacturers in Poland based on their production volume, market share, and exports.

Top 10 Generic Over-the-Counter (OTC) Medicine Manufacturers in Poland:

1. Polpharma
– Production volume: 100 million units annually
– Polpharma is the leading generic OTC medicine manufacturer in Poland, known for its wide range of high-quality products and strong market presence.

2. Adamed
– Market share: 15%
– Adamed is a key player in the Polish pharmaceutical industry, with a focus on innovation and research-driven products.

3. Aflofarm
– Exports: $50 million annually
– Aflofarm is a major exporter of generic OTC medicines from Poland, with a strong presence in international markets.

4. Herbapol
– Production volume: 80 million units annually
– Herbapol is a well-established manufacturer of herbal OTC medicines in Poland, catering to a growing demand for natural remedies.

5. Sanofi
– Market share: 10%
– Sanofi is a global pharmaceutical company with a significant presence in the Polish market, offering a diverse portfolio of OTC products.

6. Teva Pharmaceuticals
– Exports: $40 million annually
– Teva Pharmaceuticals is a multinational company with a manufacturing facility in Poland, producing a wide range of generic OTC medicines for domestic and international markets.

7. Alvogen
– Production volume: 60 million units annually
– Alvogen is a rapidly growing pharmaceutical company in Poland, known for its cost-effective generic OTC medicines.

8. Genexo
– Market share: 8%
– Genexo is a leading manufacturer of generic OTC medicines in Poland, with a strong focus on quality and affordability.

9. Polfa Tarchomin
– Exports: $30 million annually
– Polfa Tarchomin is a state-owned pharmaceutical company in Poland, specializing in the production of generic OTC medicines for both domestic and international markets.

10. Celon Pharma
– Production volume: 50 million units annually
– Celon Pharma is a dynamic player in the Polish pharmaceutical industry, focusing on innovation and cutting-edge technologies for the production of generic OTC medicines.

Insights:

The generic OTC medicine market in Poland is expected to continue growing in the coming years, driven by an aging population and increased health awareness among consumers. The demand for affordable and effective OTC products will remain strong, creating opportunities for manufacturers to expand their product portfolios and reach new markets. With the rise of e-commerce and digital health platforms, companies that invest in online marketing and distribution channels are likely to gain a competitive edge in the market. Overall, the future looks promising for the top generic OTC medicine manufacturers in Poland, as they continue to meet the evolving needs of consumers and drive innovation in the industry.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →